ClinVar

Description

We have classified this variant using ACMG criteria (Richards et al., 2015) in November of 2020. These criteria are not applicable for novel gene identification and have limited utility for significant novel phenotype expansion.Classification is provided for established TUBA1A-associated tubulinopathy phenotypes, but excludes novel phenotypes that have been observed in the proband with this variant but are not yet well established in association with TUBA1A variants, e.g. congenital fibrosis of the extraocular muscles. We have thus classified the p.(Arg156His) variant as likely pathogenic for classic tubulinopathy phenotypes based on the following evidence: 1) The p.(Arg156His) variant is a non-truncating nonsynonymous variant in a residue located in the α helix H4 of TUBA1A. This is a functionally important region which is depleted of benign missense variants, and other residues within α helix H4 have been previously associated with tubulinopathies (PM1_Moderate). 2) The p.(Arg156His) variant has not been reported in the gnomAD database (PM2_Moderate). 3) The variant occurs de novo in the proband and has not been identified in any other family members. Paternity and maternity has been confirmed. (PS2_Strong). 4) The TUBA1A gene is lacking in missense benign variants, and missense TUBA1A variants are a common mechanism of disease. The gene is heavily missense constrained (PP2_Supporting).